3Indexed trials
drug · Product Intelligence
Solanezumab
Pipeline Intelligence
Solanezumab: 3 indexed trials, 1 sponsors; 0 linked Orange Book patents and 0 FDA-linked events where matched.
1Sponsors
0Orange Book patent links
0FDA-linked events
Development evidence
NCT01127633Eli Lilly and Company · alzheimersPHASE3
NCT01148498Eli Lilly and Company · alzheimersPHASE2
NCT02008357Eli Lilly and Company · other_psychiatryPHASE3
FDA / patent evidence
No FDA Orange Book product match is asserted for this intervention.
Regulatory context
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.